Baldness reversed by chemotherapy - 24/04/13
Doi : 10.1016/j.jaad.2009.09.002
William Read, MD ⁎ 
Department of Medicine, University of California San Diego, Moores Cancer Center, San Diego, California
Reprint requests: William Read, MD, Department of Medicine, University of California San Diego, Moores Cancer Center, 3855 Health Sciences Dr #0987, San Diego, CA 92093-0987| Funding sources: None. |
|
| Conflicts of interest: The clinical trial mentioned in this report was sponsored by Aventis, the maker of docetaxel. Dr Read participated as an investigator in a subsequent clinical trial (now closed) of docetaxel in head and neck cancer, which was also sponsored by Aventis. Dr Read has no other relevant financial disclosures. |
© 2010
American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 63 - N° 4
P. 727-728 - ottobre 2010 Ritorno al numero
Articolo precedente
- A new superficial fungal infection caused by Coniosporium epidermidis
- Dong Ming Li, Xue Rong Chen
- J. Graham Smith, Jr, MD (1926-2010)
- Kim B. Yancey, Jack L. Lesher
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?